No evidence of increased risk for Coronavirus Disease 2019 (COVID-19) in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy.
J Eur Acad Dermatol Venereol
; 34(9): e433-e434, 2020 Sep.
Article
in En
| MEDLINE
| ID: mdl-32339362
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dermatitis, Atopic
/
Interleukin-4 Receptor alpha Subunit
/
Antibodies, Monoclonal, Humanized
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Europa
Language:
En
Journal:
J Eur Acad Dermatol Venereol
Journal subject:
DERMATOLOGIA
/
DOENCAS SEXUALMENTE TRANSMISSIVEIS
Year:
2020
Type:
Article
Affiliation country:
Italy